On the market-consistent valuation of health insurance liabilities
Simon Hochgerner, Jonas Ingmanns, Nicole Kastanek

TL;DR
This paper investigates the market-consistent valuation of lifelong health insurance products, highlighting the dependence on interest and inflation models and proposing a decomposition method for efficient valuation.
Contribution
It demonstrates that the Best Estimate valuation depends on the interest and inflation rate models and introduces a decomposition approach for efficient large-scale policy valuation.
Findings
Best Estimate depends on interest and inflation models.
A decomposition method separates policy data from financial instrument prices.
Efficient valuation of large policy portfolios is achievable.
Abstract
We are concerned with the market-consistent valuation of lifelong health insurance products, which are subject to adjustments derived from the actuarial equivalence principle and driven by (medical) inflation. Such products are well-established in the European national markets, and the dynamics of the adjustment mechanism is well-understood from an actuarial perspective. However, the question of market-consistent valuation (as is necessary for Solvency II reporting) has not previously been addressed. This gap has led to a situation where some practitioners use stochastic models while others rely on deterministic methods to assign market-consistent values (Best Estimates) to the same type of health insurance liabilities. The purpose of this note is to fill this gap by showing that the Best Estimate of a lifelong health insurance policy depends on the choice of model for the interest…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
